Spinocerebellar Ataxia Type 34
Neurology·MeSH: Growth Deficiency and Mental Retardation with Facial Dysmorphism
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Spinocerebellar Ataxia Type 34?
There are 1 clinical trial targeting Spinocerebellar Ataxia Type 34 tracked by BioSniper.
What is the prevalence of Spinocerebellar Ataxia Type 34?
The estimated prevalence of Spinocerebellar Ataxia Type 34 is approximately 0.1 per 100,000 population.
Deep-dive into Spinocerebellar Ataxia Type 34
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis